The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Prevalence of Diabetes Mellitus in Pancreatic Cancer Compared to Common Cancers
Open accessAbstract
OBJECTIVES: In pancreatic cancer (PaC), the prevalence of diabetes mellitus (DM), especially new-onset DM (≤36 months of PaC diagnosis), is high. To determine if this observation is unique to PaC, we compared the prevalence and characteristics of DM in lung, breast, prostate, and colorectal cancers with PaC and noncancer controls. METHODS: We retrospectively reviewed the medical records of 500 consecutive patients with cancer (100 each with lung, breast, prostate, and colorectal cancers and PaC) and 100 noncancer controls. RESULTS: Patients with PaC (mean age ± SD, 71.6 ± 9.4 years; 53% men) had a significantly (P < 0.0001) higher prevalence of DM (68%) compared to age-matched patients with lung (mean age ± SD, 71.6 ± 9.4 years; 59% men; and 19.6% DM), breast (mean age ± SD, 71.6 ± 9.6 years; 100% women; and 19.4% DM), prostate (mean age ± SD, 71.3 ± 9.4 years; 100% men; and 14.8% DM), and colorectal cancer (mean age ± SD, 71.6 ± 9.5 years; 56% men; and 20.7% DM), and noncancer controls (mean age ± SD, 70.7 ± 9.2 years; 57% men; and 23.5% DM). Among the patients with PaC, 40% developed DM in the 36 months preceding the diagnosis of PaC compared with 3.3% to 5.7% in the other groups (P < 0.0001). CONCLUSIONS: Whereas the prevalence of DM in PaC is very high, DM prevalence in other common cancers is no different from that in noncancer controls. In particular, new-onset DM is a phenomenon that is unique to PaC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The prevalence of diabetes among patients diagnosed with PDAC is remarkably higher than for any other solid tumor,211”
From Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review (2021) · cites this paper as [211]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 14,094
Diagnosis and Classification of diabetes mellitus
Rossi, G. (2014) · Diapedia.org eBooks · doi:10.14496/dia..20 · Cited by 3,212
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F., & Woodward, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602619 · Cited by 1,105
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s055 · Cited by 1,062
Vigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0087 · Cited by 1,009
Prevalence and Clinical Profile of Pancreatic Cancer–Associated Diabetes Mellitus
Pannala, R., Leirness, J. B., Bamlet, W. R., Basu, A., Petersen, G. M., & Chari, S. T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.039 · Cited by 621
Self-citationProbability of Pancreatic Cancer Following Diabetes: A Population-Based Study
Chari, S. T., Leibson, C. L., Rabe, K. G., Ransom, J., de Andrade, M., & Petersen, G. M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.007 · Cited by 603
Self-citationNew-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer
Pannala, R., Basu, A., Petersen, G. M., & Chari, S. T. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70337-1 · Cited by 577
Self-citation
Cited by
Sorted by citations
The Epidemiology of Pancreatitis and Pancreatic Cancer
Yadav, D., & Lowenfels, A. B. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.068 · Cited by 1,974
Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer
Hart, P. A., Bellin, M. D., Andersen, D. K., Bradley, D., Cruz-Monserrate, Z., Forsmark, C. E., Goodarzi, M. O., Habtezion, A., Korc, M., Kudva, Y. C., et al. (2016) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30106-6 · Cited by 551
Self-citationDiabetes, pancreatogenic diabetes, and pancreatic cancer
Andersen, D. K., Korc, M., Petersen, G. M., Eibl, G., Li, D., Rickels, M. R., Chari, S. T., & Abbruzzese, J. L. (2017) · Diabetes · doi:10.2337/db16-1477 · Cited by 516
Self-citationEarly detection of pancreatic cancer
Pereira, S. P., Oldfield, L., Ney, A., Hart, P. A., Keane, M. G., Pandol, S. J., Li, D., Greenhalf, W., Jeon, C. Y., Koay, E. J., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30416-9 · Cited by 482
New insights into pancreatic cancer-induced paraneoplastic diabetes
Sah, R. P., Nagpal, S. J. S., Mukhopadhyay, D., & Chari, S. T. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.49 · Cited by 339
Self-citationAmerican Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s004 · Cited by 285
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Cusi, K. J., Hilliard, M. E., Isaacs, D. M., et al. (2022) · Diabetes Care · doi:10.2337/dc23-s004 · Cited by 242
Lee, J. W., Kang, C. M., Choi, H. J., Lee, W. J., Song, S. Y., Lee, J., & Lee, J.-D. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.131847 · Cited by 213
ElSayed, N. A., McCoy, R. G., Aleppo, G., Bajaj, M. S., Balapattabi, K., Beverly, E. A., Early, K. B., Bruemmer, D., Cusi, K. J., Echouffo-Tcheugui, J. B., et al. (2024) · Diabetes Care · doi:10.2337/dc25-s004 · Cited by 226
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc20-s004 · Cited by 207
Association of Diabetes Mellitus and Pancreatic Adenocarcinoma: A Meta-Analysis of 88 Studies
Batabyal, P., Hoorn, S. V., Christophi, C., & Nikfarjam, M. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3625-6 · Cited by 189
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc19-s004 · Cited by 191
Liao, W., Tu, Y., Wu, M., Lin, J.-T., Wang, C., & Chien, K. (2015) · BMJ · doi:10.1136/bmj.g7371 · Cited by 175
Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review
Kenner, B., Chari, S. T., Kelsen, D., Klimstra, D. S., Pandol, S. J., Rosenthal, M., Rustgi, A. K., Taylor, J. A., Yala, A., Abul-Husn, N., et al. (2021) · Pancreas · doi:10.1097/mpa.0000000000001762 · Cited by 158
Self-citationElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Cusi, K. J., Ekhlaspour, L., Fleming, T. K., Hilliard, M. E., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc24-s004 · Cited by 173
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc21-s004 · Cited by 150
Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer
Eibl, G., Cruz‐Monserrate, Z., Korc, M., Petrov, M. S., Goodarzi, M. O., Fisher, W. E., Habtezion, A., Lugea, A., Pandol, S. J., Hart, P. A., et al. (2017) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2017.07.005 · Cited by 148
Pancreatic cancer in 2021: What you need to know to win
Tonini, V., & Zanni, M. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i35.5851 · Cited by 133
Hu, C.-M., Tien, S.-C., Hsieh, P.-K., Jeng, Y.-M., Chang, M.-C., Chang, Y.-T., Chen, Y.-J., Chen, Y.-J., Lee, E. Y.-H. P., & Lee, W.-H. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.02.005 · Cited by 123
Peng, Y.-C., Wu, C., Tien, Y., Lu, T., Wang, Y.-H., & Chen, B. (2020) · European Radiology · doi:10.1007/s00330-020-07294-7 · Cited by 105
Diabetes and pancreatic cancer: Exploring the two-way traffic
Roy, A., Sahoo, J., Kamalanathan, S., Naik, D., Mohan, P., & Kalayarasan, R. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i30.4939 · Cited by 106
Setiawan, V. W., Stram, D. O., Porcel, J., Chari, S. T., Maskarinec, G., Le Marchand, L., Wilkens, L. R., Haiman, C. A., Pandol, S. J., & Monroe, K. R. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy090 · Cited by 91
Self-citationDiabetes of the exocrine pancreas
Wynne, K., Devereaux, B., & Dornhorst, A. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14451 · Cited by 87
KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops
Eibl, G., & Rozengurt, E. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.10.007 · Cited by 88
Weight Loss, Diabetes, Fatigue, and Depression Preceding Pancreatic Cancer
Olson, S. H., Xu, Y., Herzog, K., Saldia, A., DeFilippis, E. M., Li, P. C.-W., Allen, P. J., O'Reilly, E. M., & Kurtz, R. C. (2015) · Pancreas · doi:10.1097/mpa.0000000000000590 · Cited by 85
for the European Study Group for Pancreatic Cancer, Kleeff, J. H., Costello, E., Jackson, R., Halloran, C. M., Greenhalf, W., Ghaneh, P., Lamb, R. F., Lerch, M. M., Mayerle, J. V., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.277 · Cited by 78
Molina‐Montes, E., Coscia, C., Gómez-Rubio, P., Fernández, A. M., Boenink, R., Rava, M., Márquez, M., Molero, X., Löhr, M. J., Sharp, L., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319990 · Cited by 79
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s004 · Cited by 90
Diabetes, pancreatic cancer, and metformin therapy
Gong, J., Robbins, L., Lugea, A., Waldron, R. T., Jeon, C. Y., & Pandol, S. J. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00426 · Cited by 71
Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma
Liu, Y.-H., Hu, C., Hsu, Y.-S., & Lee, W. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05259-w · Cited by 74
Yao, K., Wang, Q., Jia, J., & Zhao, H. (2017) · Tumor Biology · doi:10.1177/1010428317707882 · Cited by 61
Guideline for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition)
Guo, L., & Xiao, X. (2024) · Aging Medicine · doi:10.1002/agm2.12294 · Cited by 69
A tale of two pancreases: exocrine pathology and endocrine dysfunction
Rickels, M. R., Norris, A. W., & Hull, R. L. (2020) · Diabetologia · doi:10.1007/s00125-020-05210-8 · Cited by 60
The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells
Fu, Y., Ricciardiello, F., Yang, G., Qiu, J., Huang, H., Xiao, J., Cao, Z., Zhao, F., Liu, Y., Luo, W., et al. (2021) · Cells · doi:10.3390/cells10030497 · Cited by 59
Illés, D., Terzin, V., Holzinger, G., Kosár, K., Róka, R., Zsóri, G., Ábrahám, G., & Czakó, L. (2015) · Pancreatology · doi:10.1016/j.pan.2015.12.005 · Cited by 54
The relationship between pancreatic cancer and type 2 diabetes: cause and consequence
Li, Y., Bian, X., Wei, S., He, M., & Yang, Y. (2019) · Cancer Management and Research · doi:10.2147/cmar.s211972 · Cited by 49
Hank, T. P., Sandini, M., Qadan, M., Weniger, M., Ciprani, D., Li, A., Ferrone, C. R., Warshaw, A. L., Lillemoe, K. D., & Castillo, C. F. F.-D. (2019) · Pancreatology · doi:10.1016/j.pan.2019.10.007 · Cited by 45
Activation of GLP-1 receptor enhances the chemosensitivity of pancreatic cancer cells
Zhao, H.-J., Jiang, X., Hu, L., Yang, L., Deng, L.-D., Wang, Y.-P., & Ren, Z. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-19-0186 · Cited by 45
Obesity, obesities and gastrointestinal cancers
Zou, Y., & Pitchumoni, C. S. (2023) · Disease-a-Month · doi:10.1016/j.disamonth.2023.101592 · Cited by 47
Mannucci, A., & Goel, A. (2025) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.70035 · Cited by 54
Ose, D. J., Viskochil, R. H., Holowatyj, A. N., Larson, M., Wilson, D., Dunson, W. A., Deshmukh, V. G., Butcher, J. R., Taylor, B., Svoboda, K., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.7653 · Cited by 43
Oldfield, L. S., Evans, A., Rao, R. G., Jenkinson, C., Purewal, T. S., Psarelli, E. E., Menon, U., Timms, J. F., Pereira, S. P., Ghaneh, P., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2021.103802 · Cited by 43
Gaps and Opportunities in the Diagnosis and Treatment of Pancreatic Cancer
Caban, M., & Małecka-Wojciesko, E. (2023) · Cancers · doi:10.3390/cancers15235577 · Cited by 46
Metformin with Everolimus and Octreotide in Pancreatic Neuroendocrine Tumor Patients with Diabetes
Pusceddu, S., Buzzoni, R., Vernieri, C., Concas, L., Marceglia, S. R. F., Giacomelli, L., Milione, M., Leuzzi, L., Femia, D., Formisano, B., et al. (2016) · Future Oncology · doi:10.2217/fon-2015-0077 · Cited by 38
Galectin-3 and S100A9: Novel Diabetogenic Factors Mediating Pancreatic Cancer–Associated Diabetes
Liao, W., Huang, B., Yu, Y., Yang, H.-H., Chen, P., Huang, C., Huang, H., Wu, M., & Chow, L. (2019) · Diabetes Care · doi:10.2337/dc19-0217 · Cited by 37
Pang, W., Yao, W., Dai, X., Zhang, A., Hou, L., Wang, L., Wang, Y., Huang, X. Y., Meng, X., & Li, L. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.56271 · Cited by 38
Wang, Y., HUANG, S. H., Zhong, J., Yang, K., Guo, Z., Liu, J., Ma, L., Li, H., Ou, B.-N., & Li, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113858 · Cited by 36
Cheng, Y., Diao, D., Zhang, H., Guo, Q., Wu, X., Song, Y., & Dang, C. (2013) · Biomedical Reports · doi:10.3892/br.2013.211 · Cited by 36
Park, W. G., Li, L., Appana, S. N., Wei, W., Stello, K. M., Andersen, D. K., Hughes, S. J., Whitcomb, D. C., Brand, R. E., Yadav, D. K., et al. (2019) · Pancreatology · doi:10.1016/j.pan.2019.11.008 · Cited by 36
Relationship between pancreatic cancer‐associated diabetes and cachexia
Liao, W., Chen, P., Huang, C., Chang, Y., Huang, B., Chang, C., Wu, M., & Chow, L. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12553 · Cited by 32
Sheth, S. G., Conwell, D. L., Whitcomb, D. C., Alsante, M., Anderson, M. A., Barkin, J. S., Brand, R. E., Coté, G. A., Freedman, S. D., Gelrud, A., et al. (2017) · Pancreatology · doi:10.1016/j.pan.2017.02.015 · Cited by 31
Deng, J., Guo, Y., Du, J., Gu, J., Kong, L., Tao, B., Li, J., & Fu, D. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.844028 · Cited by 33
Chovsepian, A., Prokopchuk, O., Petrova, G., Gjini, T., Kuzi, H., Heisz, S., Janssen, K., Martignoni, M. E., Friess, H., Hauner, H., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101729 · Cited by 30
Diabetes Mellitus and Pancreatic Cancer
Hart, P. A., & Chari, S. T. (2013) · Pancreas · doi:10.1097/mpa.0b013e3182a7c963 · Cited by 30
Self-citationImmune-related somatic mutation genes are enriched in PDACs with diabetes
Wang, K., Zhou, W., Meng, P., Wang, P., Zhou, C., Yao, Y., Wu, S., Wang, Y., Zhao, J., Zou, D., et al. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.03.006 · Cited by 29
Lee, H. S., Chae, W., Sung, M. J., Keum, J., Jo, J. H., Chung, M. J., Park, J. Y., Park, S. W., Song, S. Y., Park, E., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac728 · Cited by 30
A Serum Marker for Early Pancreatic Cancer With a Possible Link to Diabetes
Nam, H., Hong, S., Jung, K. H., Kang, S., Park, M. S., Kang, S., Kim, H. S., Mai, V.-H., Kim, J., Lee, H., et al. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab191 · Cited by 29
Surveillance for neoplasia in the pancreas
Overbeek, K. A., Cahen, D. L., Canto, M. I., & Bruno, M. J. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.10.013 · Cited by 28
Paraneoplastic β Cell Dedifferentiation in Nondiabetic Patients with Pancreatic Cancer
Wang, Y., Ni, Q., Sun, J., Xu, M., Xie, J., Zhang, J., Fang, Y., Ning, G., & Wang, Q. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz224 · Cited by 29
Neural innervation in adipose tissue, gut, pancreas, and liver
Sun, M., Wan, Y., Shi, M., Meng, Z., & Zeng, W. (2023) · Life Metabolism · doi:10.1093/lifemeta/load022 · Cited by 28
Hart, P. A., Law, R. J., Frank, R. D., Bamlet, W. R., Burch, P. A., Petersen, G. M., Rabe, K. G., & Chari, S. T. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.193 · Cited by 27
Self-citationInsulin resistance and cancer: molecular links and clinical perspectives
Caturano, A., Erul, E., Nilo, R., Nilo, D., Russo, V., Rinaldi, L., Acierno, C., Gemelli, M. T., Ricotta, R., Sasso, F. C., et al. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05245-8 · Cited by 27
Is diabetes mellitus a risk factor for pancreatic cancer?
Pezzilli, R. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i30.4861 · Cited by 24
Perera, C. J., Falasca, M., Chari, S. T., Greenfield, J. R., Xu, Z., Pirola, R. C., Wilson, J. S., & Apte, M. V. (2021) · Cancers · doi:10.3390/cancers13205224 · Cited by 23
Self-citationLee, S., Hwang, H. K., Kang, C. M., & Lee, W. J. (2018) · Pancreas · doi:10.1097/mpa.0000000000001099 · Cited by 25
Park, B. K., Seo, J. H., Chung, J. B., & Choi, J. K. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01807-5 · Cited by 24
Baseline Hemoglobin-A1c Impacts Clinical Outcomes in Patients With Pancreatic Cancer
Fan, K. Y., Dholakia, A. S., Wild, A. T., Su, Z., Hacker‐Prietz, A., Kumar, R., Hodgin, M. B., Hsu, C. C.-C., Le, D. T., Jesus‐Acosta, A. D., et al. (2014) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2014.0006 · Cited by 23
Small Molecules and Pancreatic Cancer Trials and Troubles
Govardhanagiri, S., Bethi, S. R., & Nagaraju, G. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817661-0.00008-1 · Cited by 22
Duvillié, B., Kourdoughli, R., Druillennec, S., Eychène, A., & Pouponnot, C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.563267 · Cited by 22
CA19-9 capability as predictor of pancreatic cancer resectability in a Spanish cohort
Herreros‐Villanueva, M., Ruiz-Rebollo, L., Montes, M., Rodriguez-Lopez, M., Francisco, M., Cubiella, J., Iyo, E., Garabitos, E., Moneo, E. M., Martos, M., et al. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05245-5 · Cited by 22
Hsueh, H., Pita-Grisanti, V., Gumpper, K., Lahooti, A., Chavez-Tomar, M., Schadler, K., & Cruz‐Monserrate, Z. (2021) · Pancreatology · doi:10.1016/j.pan.2021.10.004 · Cited by 19
Škrha, P., Hořínek, A., Pazourková, E., Hajer, J., Fric, P., Škrha, J., & Anděl, M. (2016) · Pancreatology · doi:10.1016/j.pan.2016.05.005 · Cited by 20
Prediction of Pancreatic Cancer in Diabetes Patients with Worsening Glycemic Control
Jeon, C. Y., Kim, S., Lin, Y., Risch, H. A., Goodarzi, M. O., Nuckols, T. K., Freedland, S. J., Pandol, S. J., & Pisegna, J. R. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0712 · Cited by 20
Takeda, T., Sasaki, T., Okamoto, T., Ishitsuka, T., Yamada, M., Nakagawa, H., Mie, T., Furukawa, T., Kasuga, A., Matsuyama, M., et al. (2022) · Internal Medicine · doi:10.2169/internalmedicine.0730-22 · Cited by 19
Moz, S., Basso, D., Padoan, A., Bozzato, D., Fogar, P., Zambon, C., Pelloso, M., Sperti, C., de Kreutzenberg, S. V., Pasquali, C., et al. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.02.018 · Cited by 19
Pathogenesis of Pancreatic Cancer-Related Diabetes Mellitus
Korc, M. (2019) · Pancreas · doi:10.1097/mpa.0000000000001300 · Cited by 19
Su, J., Pang, W., Zhang, A., Li, L., Yao, W., & Dai, X. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06980-z · Cited by 18
Wu, K., Wang, W., Chen, H., Gao, W., & Yu, C. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.12.182 · Cited by 17
Early detection of sporadic pancreatic cancer: time for change
Fric, P., Šedo, A., Škrha, J., Bušek, P., Laclav, M., Škrha, P., & Zavoral, M. (2017) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000904 · Cited by 16
Pancreatic cancer trends in Europe: epidemiology and risk factors
Hawksworth, G., Hales, J., Martinez, F., Hynes, A., Hamilton, A., & Fernández, V. (2019) · Medical Studies · doi:10.5114/ms.2019.86336 · Cited by 16
Carnie, L. E., Lamarca, Á., McNamara, M. G., Bibby, N., O'Reilly, D. A., & Valle, J. W. (2020) · Pancreatology · doi:10.1016/j.pan.2020.03.020 · Cited by 16
Oldfield, L. S., Stott, M. C., Hanson, R., Jackson, R., Reynolds, W. F., Chandran-Gorner, V., Meer, R. V. D., Alison, L. J., Tejeiro, R. A., Purewal, T. S., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-068010 · Cited by 16
Wu, B. U. (2021) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000763 · Cited by 14
Ding, F., Guo, Y., Zhang, H., Zhong, Y., Zhang, D., Huang, Q., Zhou, Z., Liu, G., Zhang, X., & Weng, S. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112027 · Cited by 13
Thonsri, U., Wongkham, S., Wongkham, C., Hino, S., Nakao, M., Roytrakul, S., Koga, T., & Seubwai, W. (2020) · Cancer Science · doi:10.1111/cas.14719 · Cited by 13
A Decade Later: Revisiting the TGFβ Family’s Role in Diabetes
Brown, M., & Schneyer, A. L. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.11.006 · Cited by 13
Sohn, S. Y., Lee, E. K., Han, S., Lee, Y. J., Hwangbo, Y., Kang, Y. H., Lee, S. D., Kim, S., Woo, S. M., Lee, W. J., et al. (2018) · Medicine · doi:10.1097/md.0000000000010590 · Cited by 12
White, M. J., Sheka, A. C., LaRocca, C. J., Irey, R., Ma, S., Wirth, K. M., Benner, A., Denbo, J. W., Jensen, E. H., Ankeny, J. S., et al. (2022) · Journal of Public Health · doi:10.1093/pubmed/fdac118 · Cited by 12
Yang, K., Doege, D., Thong, M. S. Y., Koch‐Gallenkamp, L., Weißer, L., Bertram, H., Eberle, A., Holleczek, B., Nennecke, A., Waldmann, A., et al. (2023) · Cancer · doi:10.1002/cncr.35133 · Cited by 11
New onset diabetes predicts progression of low risk pancreatic mucinous cysts
Schweber, A. B., Brooks, C., Agarunov, E., Sethi, A., Poneros, J. M., Schrope, B., Kluger, M. D., Chabot, J. A., & Gonda, T. A. (2020) · Pancreatology · doi:10.1016/j.pan.2020.09.015 · Cited by 11
Park, S. H., Kang, I., Hong, S. S., Kim, H.-Y., Hwang, H. K., & Kang, C. M. (2024) · Cancers · doi:10.3390/cancers16101844 · Cited by 10
Zhao, H., Jiang, X., Duan, L., Yang, L., Wang, W., & Ren, Z. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej19-0215 · Cited by 10
Screening Strategy of Pancreatic Cancer in Patients with Diabetes Mellitus
Mizuno, S., Nakai, Y., Ishigaki, K., Saito, K., Oyama, H., Hamada, T., Suzuki, Y., Inokuma, A., Kanai, S., Noguchi, K., et al. (2020) · Diagnostics · doi:10.3390/diagnostics10080572 · Cited by 10
Carrato, A., Melisi, D., Prager, G. W., Westphalen, C. B., Ferreras, A., D’Esquermes, N., Taı̈eb, J., & Macarulla, T. M. (2021) · Future Oncology · doi:10.2217/fon-2020-0749 · Cited by 9
Bitterman, D. S., Winter, K. A., Hong, T. S., Fuchs, C. S., Regine, W. F., Abrams, R. A., Safran, H. P., Hoffman, J. P., Benson, A. B., Kasunic, T., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.08.042 · Cited by 8
Wang, C., Tseng, M., Wu, S., Yang, T., Chen, H., Sung, W., Su, C., Wang, Y., Chen, W., Lai, H., et al. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15234 · Cited by 8
Individualized diabetes care: Lessons from the real-world experience
Khor, X. Y., Pappachan, J. M., & Jeeyavudeen, M. S. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i13.2890 · Cited by 12
Early pancreatic carcinogenesis – risk factors, early symptoms, and the impact of antidiabetic drugs
Fric, P., Škrha, J., Šedo, A., Bušek, P., Kmochová, K., Laclav, M., Solař, S., Bunganič, B., & Zavoral, M. (2016) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000646 · Cited by 7
Feingold, K. R. (2015) · Europe PMC (PubMed Central) · Cited by 7
Zhou, Y., Wu, Z. K., Zeng, L., & Chen, R. (2025) · BMC Medicine · doi:10.1186/s12916-025-04048-4 · Cited by 9
Metadata
- Authors
- Aggarwal, G., Kamada, P., & Chari, S. T.
- Affiliations
- Mayo Clinic (US)
- University Medical Center Brackenridge (US)
- Corresponding author
- Aggarwal, Gaurav
- Chari, Suresh T.
- Venue
- Pancreas
- Published
- 2013-03
- Volume
- 42
- Issue
- 2
- Pages
- 198-201
- ISSN
- 0885-3177 (ISSN-L)
- PMC
- PMC3896296
- OpenAlex
- W2045036543
- Cited by
- 167
- References
- 21
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 7 · 2023: 11 · 2022: 14 · 2021: 23 · 2020: 19 · 2019: 17 · 2018: 10 · 2017: 10 · 2016: 9 · 2015: 4 · 2014: 7 · 2013: 9
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Pancreas (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (P50CA102701, R01CA100685)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- diabetes mellitus, pancreatic cancer, new-onset diabetes, cancer-associated diabetes, lung cancer, breast cancer, prostate cancer, colorectal cancer, diabetes prevalence, cancer patients
- MeSH terms
- Aged, Aged, 80 and over, Blood Glucose, Breast Neoplasms, Diabetes Mellitus, Female, Humans, Lung Neoplasms, Male, Middle Aged, Minnesota, Pancreatic Neoplasms, Prostatic Neoplasms, Retrospective Studies, Risk Factors, Time Factors, Colorectal Neoplasms, Biomarkers, Prevalence, Chi-Square Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
